Gomez, Alvaro http://orcid.org/0000-0001-9618-1755
Parodis, Ioannis http://orcid.org/0000-0002-4875-5395
Sjöwall, Christopher http://orcid.org/0000-0003-0900-2048
Funding for this research was provided by:
Reumatikerförbundet (R-941095, R-939149)
Stiftelsen Konung Gustaf V:s 80-årsfond (FAI-2020–0741, FAI-2020–0663)
Stiftelsen Professor Nanna Svartz Fond (2020–00368)
Svenska Läkaresällskapet (SLS-974449)
Nyckelfonden (OLL-974804)
Stiftelsen Ulla och Roland Gustafssons Donationsfond (2021–26)
Region Östergötland (RÖ-932055)
Stockholms Läns Landsting (FoUI-955483)
Karolinska Institutet
Karolinska Institute
Article History
Received: 19 December 2023
Accepted: 18 January 2024
First Online: 7 March 2024
Declarations
:
: IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly, Gilead, GlaxoSmithKline, Janssen, Novartis, Otsuka, and Roche. CS has received speaker’s honoraria from AstraZeneca, Novartis and Bristol-Myers Squibb. AG declares that he has no conflicts of interest related to this work. The funders had no role in the design of the study, the analyses or interpretation of data, or the writing of the manuscript.
: The study was conducted in compliance with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all study participants. Ethical permission for the present investigation was obtained from the Regional Ethics Board in Linköping (reference: M75-08; date of approval: 2008-05-22).
: Data from the current work have been previously presented at one scientific meeting [CitationRef removed].